Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05549245
Other study ID # 2022038
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 20, 2022
Est. completion date May 2023

Study information

Verified date August 2022
Source Qilu Hospital of Shandong University
Contact Dedong Ma, doctor
Phone 18560082806
Email ma@qiluhuxi.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Patients meeting the criteria of obstructive sleep apnea were included, and all patients signed informed consent, which met the requirements of the ethics Committee of our unit. All subjects were hospitalized patients. Subjects were randomly enrolled into High-flow Nasal Cannula Oxygen Therapy group or Continues Positive Airway Pressure group for 3 days of treatment. Sleep monitoring was performed on the first and fourth day of enrollment.


Recruitment information / eligibility

Status Recruiting
Enrollment 194
Est. completion date May 2023
Est. primary completion date May 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 70 Years
Eligibility Inclusion Criteria: 1. There were typical symptoms of sleep snoring at night with apnea and daytime sleepiness (ESS score =9). Stenosis and obstruction in any part of the upper airway were observed on physical examination, with AHI=5 times /h. 2. For patients with no significant daytime sleepiness (ESS score < 9), AHI=10 times /h. 3. Patients with AHI=5 times /h had one or more OSAHS complications, such as cognitive impairment, hypertension, coronary heart disease, cerebrovascular disease, diabetes and insomnia. Exclusion Criteria: 1. Patients who cannot tolerate non-invasive ventilator or transnasal high-flow oxygen therapy. 2. Ongoing treatment may affect sleep, such as sedatives, hypnotics, muscle relaxants, etc. 3. Hemodynamic instability. 4. Severe respiratory diseases.

Study Design


Intervention

Device:
high-flow nasal cannula oxygen therapy,
Patients were treated with high-flow nasal cannula oxygen therapy for three nights
CPAP
Patients were treated with CPAP for three nights

Locations

Country Name City State
China Qilu Hospital of Shandong University Jinan Shandong

Sponsors (1)

Lead Sponsor Collaborator
Qilu Hospital of Shandong University

Country where clinical trial is conducted

China, 

References & Publications (6)

Benjafield AV, Ayas NT, Eastwood PR, Heinzer R, Ip MSM, Morrell MJ, Nunez CM, Patel SR, Penzel T, Pépin JL, Peppard PE, Sinha S, Tufik S, Valentine K, Malhotra A. Estimation of the global prevalence and burden of obstructive sleep apnoea: a literature-based analysis. Lancet Respir Med. 2019 Aug;7(8):687-698. doi: 10.1016/S2213-2600(19)30198-5. Epub 2019 Jul 9. Review. — View Citation

Jordan AS, McSharry DG, Malhotra A. Adult obstructive sleep apnoea. Lancet. 2014 Feb 22;383(9918):736-47. doi: 10.1016/S0140-6736(13)60734-5. Epub 2013 Aug 2. Review. — View Citation

Nakanishi N, Suzuki Y, Ishihara M, Ueno Y, Tane N, Tsunano Y, Itagaki T, Oto J. Effect of High-Flow Nasal Cannula on Sleep-disordered Breathing and Sleep Quality in Patients With Acute Stroke. Cureus. 2020 Jul 20;12(7):e9303. doi: 10.7759/cureus.9303. — View Citation

Nilius G, Wessendorf T, Maurer J, Stoohs R, Patil SP, Schubert N, Schneider H. Predictors for treating obstructive sleep apnea with an open nasal cannula system (transnasal insufflation). Chest. 2010 Mar;137(3):521-8. doi: 10.1378/chest.09-0357. Epub 2009 Dec 1. — View Citation

Parke RL, McGuinness SP. Pressures delivered by nasal high flow oxygen during all phases of the respiratory cycle. Respir Care. 2013 Oct;58(10):1621-4. doi: 10.4187/respcare.02358. Epub 2013 Mar 19. — View Citation

Yan H, Qinghua L, Mengyuan P, Yaoyu C, Long Z, Mengjie L, Xiaosong D, Fang H. High flow nasal cannula therapy for obstructive sleep apnea in adults. Sleep Breath. 2022 Jun;26(2):783-791. doi: 10.1007/s11325-021-02453-6. Epub 2021 Aug 12. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary AHI Apnea Hypopnea Index:The number of episodes of sleep apnea per hour The first day of enrollment
Primary AHI Apnea Hypopnea Index:The number of episodes of sleep apnea per hour The fourth day of enrollment
Primary Treatment failure rate Number of patients unable to tolerate treatment/enrollment The fourth day of enrollment
Primary Good compliance rate Number of patients treated for more than 4 hours per night/enrolled The fourth day of enrollment
Primary longest apnea time Maximum duration(s) of nocturnal sleep apnea in patients The first day of enrollment
Primary longest apnea time Maximum duration(s) of nocturnal sleep apnea in patients The fourth day of enrollment
Primary Mean oxygen saturation Mean oxygen saturation during the patient's night sleep The first day of enrollment
Primary Mean oxygen saturation Mean oxygen saturation during the patient's night sleep The fourth day of enrollment
Primary minimum oxygen saturation Lowest oxygen saturation during the patient's night sleep The first day of enrollment
Primary minimum oxygen saturation Lowest oxygen saturation during the patient's night sleep The fourth day of enrollment
Secondary Gender Male and female The first day of enrollment
Secondary height Height (in cm) The first day of enrollment
Secondary age years The first day of enrollment
Secondary weight Kg The first day of enrollment
Secondary total sleep time Total sleep duration(min) of the patient at night The first day of enrollment
Secondary total sleep time Total sleep duration(min) of the patient at night The fourth day of enrollment
Secondary Number of awakening The number of awakenings during the patient's night sleep The first day of enrollment
Secondary Number of awakening The number of awakenings during the patient's night sleep The fourth day of enrollment
See also
  Status Clinical Trial Phase
Recruiting NCT05857384 - Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs Phase 1
Recruiting NCT04547543 - Follow-up of Apneic Patients by Visio-consultation N/A
Recruiting NCT05371509 - Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study N/A
Completed NCT02515357 - Mediterranean Diet/Lifestyle Intervention in Obstructive Sleep Apnea N/A
Completed NCT05582070 - Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction N/A
Active, not recruiting NCT03189173 - Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea Phase 2
Completed NCT04084899 - The Effect of CPAP on Lung Hyperinflation in Patients With OSA
Completed NCT03032029 - Registry on the Treatment of Central and Complex Sleep-Disordered Breathing With Adaptive Servo-Ventilation
Recruiting NCT04028011 - Clinical Evaluation of a Wearable Technology for the Diagnosis of Sleep Apnoea
Recruiting NCT06047353 - Community Health Advocates for Motivating PAP Use in Our Neighborhoods. N/A
Completed NCT05253963 - Acute Effect of CPAP on Weight in Patients With Obstructive Sleep Apnea N/A
Recruiting NCT06029959 - Stroke and CPAP Outcome Study 3 N/A
Recruiting NCT06150352 - Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
Completed NCT03589417 - Postural Stability, Balance and Fall Risk in Patients With Obstructive Sleep Apnea
Recruiting NCT04335994 - ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing N/A
Withdrawn NCT04063436 - Evaluation of a New Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea N/A
Recruiting NCT05385302 - Sociological Determinants of Positive Airway Pressure Adherence in OSA Patients
Recruiting NCT04572269 - Metabolomics of Obstructive Sleep Apnea
Not yet recruiting NCT06467682 - 12-week Tele-exercise Program in Patients With OSA N/A
Withdrawn NCT04011358 - Retinal Vein Occlusion and Obstructive Sleep Apnea: A Case Control Study N/A